How GSK reorganised its brand portfolio in response to Covid-19

How GSK reorganised its brand portfolio in response to Covid-19

By prioritising “ruthlessly” and unleashing the power of rapid decision making, pharmaceutical giant GlaxoSmithKline has been able to stay ahead of the curve during the Covid-19 pandemic, says global CMO Tamara Rogers. Speaking yesterday (24 June) at Cannes Lions...